|[November 19, 2012]
Clontech Selects, Endorses SnapGene Software
CHICAGO --(Business Wire)--
Biotech announced today that Clontech Laboratories Inc. has selected
the company's flagship software product, SnapGene™,
as a solution for cloning simulation and plasmid map drawing. Clontech
researchers participated in SnapGene beta testing and provided feedback
to SnapGene's developers on the interface and functionality, including
SnapGene's unique ability to simulate Clontech's In-Fusion
cloning. Andrew Farmer, Vice President of Research and Development
at Clontech, said, "Our research scientists embraced SnapGene because of
its beautiful and intuitive interface. We are now able to clone more
accurately and efficiently."
In-Fusion cloning is a revolutionary method for creating seamless gene
fusions. As demonstrated in a brief video,
SnapGene makes it trivially easy to design In-Fusion procedures. Farmer
stated, "I am pleased to recommend this software as the ideal partner
for our In-Fusion cloning kits."
Aline Glick, Vice President of Product Management at GSL Biotech, said,
"I am thrilled to count Clontech among our customers, and to see
Clontech endorse SnapGene as the software partner for their In-Fusion
cloning kits. SnapGene is still in active development, and we look
forward to continuing and deepening our collaboration with Clotech."
About GSL Biotech
Biotech was founded by scientists and software designers to meet the
everyday needs of molecular biologists. GSL's SnapGene software (snapgene.com)
provides a simple yet powerful way for researchers to plan, visualize,
document, and share their everyday molecular biology procedures. Free
trials of the software are available from the SnapGene website.
In addition to the fully functional paid product, GSL Biotech offers the
Viewer, which includes the key visualization tools of SnapGene, and
allows researchers to make DNA maps and design primers. The annotated
sequence files can be shared with colleagues or customers.
About Clontech Laboratories, Inc.
Laboratories, Inc., a wholly-owned subsidiary of Takara Bio Inc.,
develops, manufactures, and distributes a wide range of life science
research reagents under the Clontech and Takara brands. Key products
include the Living Colors fluorescent proteins; high-performance qPCR
and PCR (News - Alert) reagents (including the Ex Taq™, LA Taq™,
Titanium®, and Advantage® enzymes); RT enzymes and SMART™ library
construction kits; the innovative In-Fusion® cloning system; Tet-based
inducible gene expression systems; and a range of Macherey-Nagel nucleic
acid purification tools. These and other products support applications
including gene discovery, regulation, and function; protein expression
and purification; RNAi and stem cell studies; and plant and food
research. For more information, visit www.clontech.com.
About Takara Bio Inc.
Bio Inc. is an innovative biotechnology company based in Shiga,
Japan. As a world leader in biotechnology research and development,
Takara Bio was the first company to market PCR technology in Japan and
is also the developer of the RetroNectin® reagent, which is used as a
world-standard in gene therapy protocols. In addition to providing
research reagents and equipment to the life science research market,
Takara Bio has active research and product development activities in the
fields of gene and cell-based therapy, and agricultural biotechnology;
and is committed to preventing disease and improving the quality of life
for all people through the use of biotechnology. Through strategic
alliances with other industry leaders, the Company aims to extend its
reach around the world. More information is available at http://www.takara-bio.com.
[ InfoTech Spotlight's Homepage ]